Teishima J, Hara T, Tobe T, Hirata J, Ueki H, Wakita N, Shiraishi Y, Okamura Y, Bando Y, Terakawa T, Furukawa J, Harada K- ichi, Nakano Y, Fujisawa M. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma . CUAJ [Internet]. 2024 Jan. 30 [cited 2024 May 13];18(5):E162-6. Available from: https://cuaj.ca/index.php/journal/article/view/8548